About Neurotype
Neurotype is a company based in Minneapolis (United States) founded in 2019 by Scott Burwell. Neurotype offers products and services including NeuromarkRâ„¢ Platform. Neurotype operates in a competitive market with competitors including Pivot, Chrono Therapeutics, e-Nicotine Technology, Velectron labs and Lana Exprience, among others.
- Headquarter Minneapolis, United States
- Founders Scott Burwell
- SectorsHealthcare
- Email••••••••
- Website neurotype.io
- Social LinkedIn X
- Legal Name Neurotype Inc.
- Latest Funding Round$328.96K (USD), Grant
Sep 2023
- Investors
Products & Services of Neurotype
Neurotype offers a comprehensive portfolio of products and services, including NeuromarkR™ Platform.
Device for monitoring and managing triggers in substance use recovery.
Funding Insights of Neurotype
- Total Rounds 3
- Last Round Grant — $328,963
- First Round $404,911
(Sep 2020)
- Investors Count 1
All 3 funding rounds of Neurotype with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Neurotype
Neurotype has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Neurotype
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neurotype
1 people are tracked at Neurotype (1 in leadership).
| Name | Role | Group |
|---|---|---|
Scott Burwell | Founder & CEO | Leadership |
Complete people profiles for Neurotype
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neurotype
3 dated milestones of Neurotype across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Neurotype is founded.
- Funding First funding round of $405K.
- Funding Latest funding round, Grant, of $329K.
Competitors of Neurotype
Neurotype operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pivot, Chrono Therapeutics, e-Nicotine Technology, Velectron labs and Lana Exprience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pivot.co | 2015 | San Carlos, United States | $43.3M | 60 | Digital health solutions for tobacco cessation are provided by Pivot. | |
| chronothera.com | 2004 | Waltham, United States | $82.2M | – | Develops transdermal nicotine replacement therapy for smoking cessation. | |
| enicotinetechnology.com | 2012 | Los Gatos, United States | $3.98M | – | Nicotine Delivery with e-health tools to help individuals transition from smoking. | |
| voidelectron.com | 2018 | Bengaluru, India | $40,890 | – | Wearable anti-addiction devices are developed for customer support. | |
| lanaexperience.com | 2022 | Oman | – | – | Offers smart solutions for individuals dealing with substance use disorders. | |
| odenhealthsolutions.com | 2020 | Coquitlam, Canada | – | – | Delivers comprehensive drug overdose detection devices for addiction treatment programs. |
Detailed competitors of Neurotype
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Neurotype
10 companies that operate in the same segment as Neurotype (Health Monitoring & Wearables), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,660 | |
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Health-tracking smart rings and biosensors are developed for biometric monitoring. | 2013 | Oulu, North Ostrobothnia, Finland | USD 1.32 B | – | – | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
AI-based mobile app tracks and predicts menstrual cycles. | 2015 | London, England, United Kingdom | USD 269 M | – | – | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
Provider of a fertility tracking app that doubles as birth control | 2013 | Stockholm, Sweden | USD 99.5 M | – | – | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neurotype
Neurotype was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Neurotype is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Scott Burwell is the current CEO of Neurotype. They have also founded this company.
Neurotype was founded in 2019 in Minneapolis, United States, within the neurotechnology sector. Brain sensors and digital therapeutics are being developed to support treatment of craving in drug and food addictions. Neurofeedback systems and related tools are offered to identify and manage triggers. Operations center on advancing addiction therapies through sensor-based interventions and digital platforms.
Neurotype's top competitors include Pivot, e-Nicotine Technology and Velectron labs.
Neurotype offers NeuromarkRâ„¢ Platform.
Neurotype has 1 investor. Key investors include HHS.
Neurotype operates through Neurotype Inc..